nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—CYP3A4—Esomeprazole—Barrett's esophagus	0.204	0.389	CbGbCtD
Canagliflozin—ABCB1—Omeprazole—Barrett's esophagus	0.201	0.382	CbGbCtD
Canagliflozin—CYP3A4—Omeprazole—Barrett's esophagus	0.12	0.229	CbGbCtD
Canagliflozin—ORM1—bile—Barrett's esophagus	0.0436	0.333	CbGeAlD
Canagliflozin—ABCC2—bile—Barrett's esophagus	0.0358	0.274	CbGeAlD
Canagliflozin—SLC5A1—epithelium—Barrett's esophagus	0.0189	0.144	CbGeAlD
Canagliflozin—SLC5A1—digestive system—Barrett's esophagus	0.0144	0.11	CbGeAlD
Canagliflozin—Multiple fractures—Omeprazole—Barrett's esophagus	0.0102	0.035	CcSEcCtD
Canagliflozin—Multiple fractures—Esomeprazole—Barrett's esophagus	0.0102	0.035	CcSEcCtD
Canagliflozin—Fracture—Esomeprazole—Barrett's esophagus	0.0102	0.035	CcSEcCtD
Canagliflozin—Fracture—Omeprazole—Barrett's esophagus	0.0102	0.035	CcSEcCtD
Canagliflozin—UGT1A9—digestive system—Barrett's esophagus	0.00904	0.0691	CbGeAlD
Canagliflozin—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00776	0.0266	CcSEcCtD
Canagliflozin—Rash erythematous—Omeprazole—Barrett's esophagus	0.00776	0.0266	CcSEcCtD
Canagliflozin—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.0058	0.0199	CcSEcCtD
Canagliflozin—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.0058	0.0199	CcSEcCtD
Canagliflozin—Cystitis—Omeprazole—Barrett's esophagus	0.00574	0.0197	CcSEcCtD
Canagliflozin—Cystitis—Esomeprazole—Barrett's esophagus	0.00574	0.0197	CcSEcCtD
Canagliflozin—Vaginal infection—Omeprazole—Barrett's esophagus	0.00561	0.0192	CcSEcCtD
Canagliflozin—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00561	0.0192	CcSEcCtD
Canagliflozin—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.0054	0.0185	CcSEcCtD
Canagliflozin—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.0054	0.0185	CcSEcCtD
Canagliflozin—Urine output increased—Esomeprazole—Barrett's esophagus	0.00537	0.0184	CcSEcCtD
Canagliflozin—Urine output increased—Omeprazole—Barrett's esophagus	0.00537	0.0184	CcSEcCtD
Canagliflozin—Bladder pain—Omeprazole—Barrett's esophagus	0.00537	0.0184	CcSEcCtD
Canagliflozin—Bladder pain—Esomeprazole—Barrett's esophagus	0.00537	0.0184	CcSEcCtD
Canagliflozin—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00491	0.0168	CcSEcCtD
Canagliflozin—Polyuria—Esomeprazole—Barrett's esophagus	0.00491	0.0168	CcSEcCtD
Canagliflozin—Photosensitivity—Omeprazole—Barrett's esophagus	0.00491	0.0168	CcSEcCtD
Canagliflozin—Polyuria—Omeprazole—Barrett's esophagus	0.00491	0.0168	CcSEcCtD
Canagliflozin—Thirst—Omeprazole—Barrett's esophagus	0.00453	0.0155	CcSEcCtD
Canagliflozin—Thirst—Esomeprazole—Barrett's esophagus	0.00453	0.0155	CcSEcCtD
Canagliflozin—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00442	0.0151	CcSEcCtD
Canagliflozin—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00442	0.0151	CcSEcCtD
Canagliflozin—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00404	0.0778	CbGpPWpGaD
Canagliflozin—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00404	0.0138	CcSEcCtD
Canagliflozin—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00404	0.0138	CcSEcCtD
Canagliflozin—ABCC2—digestive system—Barrett's esophagus	0.00391	0.0299	CbGeAlD
Canagliflozin—Breast disorder—Esomeprazole—Barrett's esophagus	0.0039	0.0133	CcSEcCtD
Canagliflozin—Breast disorder—Omeprazole—Barrett's esophagus	0.0039	0.0133	CcSEcCtD
Canagliflozin—Pancreatitis—Omeprazole—Barrett's esophagus	0.00365	0.0125	CcSEcCtD
Canagliflozin—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00365	0.0125	CcSEcCtD
Canagliflozin—Pollakiuria—Omeprazole—Barrett's esophagus	0.00344	0.0118	CcSEcCtD
Canagliflozin—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00344	0.0118	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.0034	0.0117	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.0034	0.0117	CcSEcCtD
Canagliflozin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00323	0.0111	CcSEcCtD
Canagliflozin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00323	0.0111	CcSEcCtD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.003	0.0576	CbGpPWpGaD
Canagliflozin—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00295	0.0101	CcSEcCtD
Canagliflozin—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00295	0.0101	CcSEcCtD
Canagliflozin—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00292	0.01	CcSEcCtD
Canagliflozin—Urethral disorder—Omeprazole—Barrett's esophagus	0.00292	0.01	CcSEcCtD
Canagliflozin—Malnutrition—Esomeprazole—Barrett's esophagus	0.0026	0.0089	CcSEcCtD
Canagliflozin—Malnutrition—Omeprazole—Barrett's esophagus	0.0026	0.0089	CcSEcCtD
Canagliflozin—Angioedema—Esomeprazole—Barrett's esophagus	0.00237	0.00813	CcSEcCtD
Canagliflozin—Angioedema—Omeprazole—Barrett's esophagus	0.00237	0.00813	CcSEcCtD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00232	0.0447	CbGpPWpGaD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00232	0.0447	CbGpPWpGaD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.0022	0.00752	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.0022	0.00752	CcSEcCtD
Canagliflozin—Dry mouth—Omeprazole—Barrett's esophagus	0.00216	0.00741	CcSEcCtD
Canagliflozin—Dry mouth—Esomeprazole—Barrett's esophagus	0.00216	0.00741	CcSEcCtD
Canagliflozin—Infection—Esomeprazole—Barrett's esophagus	0.00211	0.00721	CcSEcCtD
Canagliflozin—Infection—Omeprazole—Barrett's esophagus	0.00211	0.00721	CcSEcCtD
Canagliflozin—Shock—Esomeprazole—Barrett's esophagus	0.00209	0.00714	CcSEcCtD
Canagliflozin—Shock—Omeprazole—Barrett's esophagus	0.00209	0.00714	CcSEcCtD
Canagliflozin—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00208	0.00712	CcSEcCtD
Canagliflozin—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00208	0.00712	CcSEcCtD
Canagliflozin—Skin disorder—Esomeprazole—Barrett's esophagus	0.00206	0.00705	CcSEcCtD
Canagliflozin—Skin disorder—Omeprazole—Barrett's esophagus	0.00206	0.00705	CcSEcCtD
Canagliflozin—CYP3A4—digestive system—Barrett's esophagus	0.00199	0.0152	CbGeAlD
Canagliflozin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.0019	0.0366	CbGpPWpGaD
Canagliflozin—ABCB1—epithelium—Barrett's esophagus	0.00185	0.0141	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00183	0.00627	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00183	0.00627	CcSEcCtD
Canagliflozin—Fatigue—Esomeprazole—Barrett's esophagus	0.00183	0.00626	CcSEcCtD
Canagliflozin—Fatigue—Omeprazole—Barrett's esophagus	0.00183	0.00626	CcSEcCtD
Canagliflozin—Constipation—Omeprazole—Barrett's esophagus	0.00181	0.00621	CcSEcCtD
Canagliflozin—Constipation—Esomeprazole—Barrett's esophagus	0.00181	0.00621	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—CYP26A1—Barrett's esophagus	0.00176	0.0338	CbGpPWpGaD
Canagliflozin—UGT2B4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00173	0.0334	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00173	0.00594	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00173	0.00594	CcSEcCtD
Canagliflozin—Urticaria—Omeprazole—Barrett's esophagus	0.00168	0.00577	CcSEcCtD
Canagliflozin—Urticaria—Esomeprazole—Barrett's esophagus	0.00168	0.00577	CcSEcCtD
Canagliflozin—Abdominal pain—Omeprazole—Barrett's esophagus	0.00168	0.00574	CcSEcCtD
Canagliflozin—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00168	0.00574	CcSEcCtD
Canagliflozin—UGT1A9—Irinotecan Pathway—APC—Barrett's esophagus	0.00165	0.0318	CbGpPWpGaD
Canagliflozin—ABCC2—Irinotecan Pathway—APC—Barrett's esophagus	0.00161	0.031	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00156	0.00535	CcSEcCtD
Canagliflozin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00156	0.00535	CcSEcCtD
Canagliflozin—Asthenia—Esomeprazole—Barrett's esophagus	0.00152	0.00521	CcSEcCtD
Canagliflozin—Asthenia—Omeprazole—Barrett's esophagus	0.00152	0.00521	CcSEcCtD
Canagliflozin—Pruritus—Esomeprazole—Barrett's esophagus	0.0015	0.00514	CcSEcCtD
Canagliflozin—Pruritus—Omeprazole—Barrett's esophagus	0.0015	0.00514	CcSEcCtD
Canagliflozin—ABCB1—digestive system—Barrett's esophagus	0.00141	0.0107	CbGeAlD
Canagliflozin—Dizziness—Esomeprazole—Barrett's esophagus	0.0014	0.0048	CcSEcCtD
Canagliflozin—Dizziness—Omeprazole—Barrett's esophagus	0.0014	0.0048	CcSEcCtD
Canagliflozin—Rash—Omeprazole—Barrett's esophagus	0.00134	0.00458	CcSEcCtD
Canagliflozin—Rash—Esomeprazole—Barrett's esophagus	0.00134	0.00458	CcSEcCtD
Canagliflozin—Dermatitis—Omeprazole—Barrett's esophagus	0.00134	0.00457	CcSEcCtD
Canagliflozin—Dermatitis—Esomeprazole—Barrett's esophagus	0.00134	0.00457	CcSEcCtD
Canagliflozin—Nausea—Esomeprazole—Barrett's esophagus	0.00126	0.00431	CcSEcCtD
Canagliflozin—Nausea—Omeprazole—Barrett's esophagus	0.00126	0.00431	CcSEcCtD
Canagliflozin—SLC5A1—NRF2 pathway—HGF—Barrett's esophagus	0.00119	0.0229	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—HGF—Barrett's esophagus	0.00119	0.0229	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—SLC9A1—Barrett's esophagus	0.00118	0.0228	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—SLC9A1—Barrett's esophagus	0.00118	0.0228	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.00118	0.0227	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.00118	0.0227	CbGpPWpGaD
Canagliflozin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00117	0.0225	CbGpPWpGaD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00109	0.021	CbGpPWpGaD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00109	0.021	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000978	0.0188	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000978	0.0188	CbGpPWpGaD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000764	0.0147	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000702	0.0135	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000673	0.0129	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000673	0.0129	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000651	0.0125	CbGpPWpGaD
Canagliflozin—UGT1A9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000642	0.0123	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000599	0.0115	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000599	0.0115	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGES—Barrett's esophagus	0.000514	0.00989	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGES—Barrett's esophagus	0.000514	0.00989	CbGpPWpGaD
Canagliflozin—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000467	0.00897	CbGpPWpGaD
Canagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000427	0.00822	CbGpPWpGaD
Canagliflozin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000422	0.00811	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGES—Barrett's esophagus	0.000397	0.00763	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CYP26A1—Barrett's esophagus	0.00039	0.00749	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CYP26A1—Barrett's esophagus	0.00039	0.00749	CbGpPWpGaD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000359	0.00691	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000346	0.00666	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—HGF—Barrett's esophagus	0.000341	0.00655	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—SLC9A1—Barrett's esophagus	0.000335	0.00645	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—SLC9A1—Barrett's esophagus	0.000335	0.00645	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—HGF—Barrett's esophagus	0.000332	0.00639	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00033	0.00634	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000306	0.00589	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CYP26A1—Barrett's esophagus	0.000301	0.00578	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.0003	0.00577	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000289	0.00555	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—SLC9A1—Barrett's esophagus	0.000281	0.0054	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—SLC9A1—Barrett's esophagus	0.000281	0.0054	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000275	0.00529	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000273	0.00525	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.00024	0.00462	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000221	0.00426	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—SLC9A1—Barrett's esophagus	0.000217	0.00417	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000207	0.00397	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000195	0.00376	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000184	0.00354	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000181	0.00349	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000176	0.00339	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000173	0.00332	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000167	0.00321	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—APC—Barrett's esophagus	0.000159	0.00305	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—APC—Barrett's esophagus	0.000159	0.00305	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000155	0.00298	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000151	0.0029	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGES—Barrett's esophagus	0.000147	0.00283	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000146	0.00281	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.00014	0.00269	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000128	0.00247	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PPARG—Barrett's esophagus	0.000128	0.00247	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PPARG—Barrett's esophagus	0.000128	0.00247	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000128	0.00246	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTGS2—Barrett's esophagus	0.00012	0.00232	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTGS2—Barrett's esophagus	0.00012	0.00232	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TP53—Barrett's esophagus	0.000113	0.00217	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP26A1—Barrett's esophagus	0.000111	0.00214	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—Barrett's esophagus	0.000101	0.00194	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—Barrett's esophagus	0.000101	0.00194	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARG—Barrett's esophagus	9.9e-05	0.0019	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	9.36e-05	0.0018	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	8.97e-05	0.00173	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	8.22e-05	0.00158	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC9A1—Barrett's esophagus	8.02e-05	0.00154	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.86e-05	0.00151	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—Barrett's esophagus	7.78e-05	0.0015	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGES—Barrett's esophagus	7.69e-05	0.00148	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.11e-05	0.00137	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGES—Barrett's esophagus	6.74e-05	0.0013	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—HGF—Barrett's esophagus	6.6e-05	0.00127	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.47e-05	0.00124	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP26A1—Barrett's esophagus	5.83e-05	0.00112	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	5.11e-05	0.000982	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.31e-05	0.000828	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.23e-05	0.000814	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC9A1—Barrett's esophagus	4.2e-05	0.000808	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGES—Barrett's esophagus	4.15e-05	0.000798	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	3.68e-05	0.000708	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—Barrett's esophagus	3.66e-05	0.000705	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.39e-05	0.000652	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	3.15e-05	0.000605	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—Barrett's esophagus	2.88e-05	0.000554	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.27e-05	0.000436	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—Barrett's esophagus	2.21e-05	0.000426	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—Barrett's esophagus	1.92e-05	0.000369	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.68e-05	0.000323	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—Barrett's esophagus	1.51e-05	0.00029	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.32e-05	0.000254	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.04e-05	0.000199	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	8.14e-06	0.000157	CbGpPWpGaD
